Aehr Test Systems, Inc. designs, manufactures, and sells systems for testing, burning-in, and monitoring semiconductor devices at the wafer level, singulated die, or packaged part form. The company's core business centers on advanced burn-in testing equipment, particularly for high-power semiconductors like silicon carbide (SiC) power devices used in electric vehicles (EVs) and power management, as well as emerging applications in AI processors and data centers. In the competitive semiconductor equipment industry, Aehr maintains niche leadership in wafer-level test and burn-in solutions, setting itself apart with its FOX-XP and FOX-CP systems tailored for next-generation chips. From what I see, this positioning in high-growth areas like AI infrastructure and EVs has contributed significantly to the recent stock price strength, as demand surges for reliable testing of complex, high-reliability chips.
Over the last 30 days, AEHR stock rose from a closing price of approximately $36.31 to $80.85, marking a +123% gain. The movement proved highly volatile and trend-driven, featuring sharp spikes after key announcements, including multi-day surges exceeding 50% in a single week.
In the past quarter, the stock advanced from around $28.81 to $80.85, delivering a +181% increase. This performance showed a steady uptrend with bouts of volatility and accelerated gains in the final month tied to AI catalysts. It clearly outpaced broader market trends, highlighting sector-specific momentum.
The main catalyst came from a record $41 million production order from a leading hyperscale AI customer for package-level burn-in testing of custom AI processor application-specific integrated circuits (ASICs), which sparked a 15%+ single-day surge. This built on second-half bookings surpassing $92 million, pointing to robust demand. Q3 fiscal earnings reported on April 7 showed revenue of $10.3 million, missing expectations, but EPS beat at -$0.05 alongside $37 million in bookings from AI and data center demand, which lifted sentiment. I also reviewed analyst notes emphasizing momentum, including golden cross technical patterns and outperformance against computer peers. Sector tailwinds from AI chip testing enthusiasm added further lift. One thing that stands out is how I cross-checked these trends using Tickeron’s AI Trend Prediction Engine, which aligned with the bullish signals.
The quarter's +181% rally was driven by sustained AI and data center semiconductor demand, with Aehr securing multiple FOX XP system deals connected to infrastructure growth. Fiscal Q2 results in early January reinstated guidance amid better AI processor visibility, despite softer revenue, establishing a bullish outlook. Broader developments, like the semiconductor rally sparked by NVDA and AVGO, heightened exposure. Institutional interest rose alongside high trading volumes, while favorable macro conditions for tech spending and lower rates bolstered high-beta (2.29) stocks like AEHR. In my view, cumulative AI orders had the most substantial impact here.
One resource I've found valuable for navigating stocks like AEHR is Tickeron’s Trending AI Robots page, which highlights top-performing AI trading bots from its library of hundreds of algorithms trading thousands of tickers across markets. These bots are selected based on recent metrics like win rate, profit factor, and Sharpe ratio, covering strategies from short-term scalping to long-term trend following. Each includes details on timeframe, risk level, historical performance, and assets, making it straightforward to find ones that fit volatile, AI-driven plays. I check this page regularly to see how automated strategies are handling similar trends.
Looking ahead, I'm watching fiscal Q4 earnings around July 2026 for insights into AI order fulfillment and backlog conversion. Ongoing hyperscale customer wins and silicon photonics progress could keep the momentum going. Broader trends in AI data centers and EV power semis will remain critical, as will macro factors like interest rates affecting tech capex. On the risk side, supply chain disruptions or revenue shortfalls bear monitoring, while new partnerships could spark further upside. This is important because it shapes the path forward in this fast-moving sector.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
On June 11, 2026, the Stochastic Oscillator for AEHR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on June 17, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 249 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on June 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 43, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AEHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AEHR's P/B Ratio (26.110) is slightly higher than the industry average of (12.228). P/E Ratio (19.449) is within average values for comparable stocks, (117.635). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.179). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (76.923) is also within normal values, averaging (185.394).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment